CNS Drugs

, Volume 9, Supplement 1, pp 29–39

Economic Impact of Stroke and Implications for Interventions

Authors

  • Curtis Benesch
    • Department of NeurologyUniversity of Rochester School of Medicine and Dentistry
  • Robert G. Holloway
    • Department of NeurologyUniversity of Rochester School of Medicine and Dentistry
Review Article

DOI: 10.2165/00023210-199809001-00004

Cite this article as:
Benesch, C. & Holloway, R.G. Mol Diag Ther (1998) 9: 29. doi:10.2165/00023210-199809001-00004

Summary

Stroke causes an enormous health and economic burden throughout the world and nearly 5% of total healthcare costs in industrialised countries are attributable to the medical costs of its stroke victims. As countries and healthcare delivery systems try to economise without compromising quality, a growing body of data is emerging that attempts to characterise the economic burden and determinants of stroke costs as well as to define the most cost-effective treatment strategies. Factors contributing to the variation in stroke costs, both within and between countries, include patient-level factors, variations in physicians’ practice styles, the specialty of the attending physician, type of hospital, type of health insurance, and methods used in managed care. Cost-effectiveness analyses have begun to provide information about the relative value of various diagnostic and treatment strategies for patients with cerebrovascular disease.

Copyright information

© Adis International Limited 1998